VEENAT contains Imatinib Mesylate which is purposely indicated for the treatment of patients with Chronic Myeloid Leukemia in blast crisis, accelerated phase, or in chronic phase.
This is strictly advised to commence the therapy under experienced medical guidance for patient who undergo to Chronic Myeloid Leukemia. For the purpose of better result, prescribed dose should be administered orally, with a meal and a large glass of water. Doses of VEENAT capsule - 400mg under chronic phase and VEENAT capsule - 600mg under accelerated phase are suggested to administer once daily or as prescribed by concerned doctor.
Some general side effects of Veenat mainly include nausea, vomiting, diarrhea, muscle cramps. In any case if you persist any of them, you are advised to consult with your doctor straight away.
NOTE : Before administering this drug you are sincerely advised to consult with your health care professional.